SSRP1 and neoplasm: In the present study, we carried out systemic bioinformatic analyses of public-available MB tumor datasets as well as whole-genome functional genomic screening data of patient-derived primary tumor lines, and identified SSRP1 as the top drug target candidate among epigenetic modulators in MYCamp-G3-MB.